Zurn Elkay Water Solutions' Review Following 22% Stock Decline Since Q2 Results
<p><a href='https://financialmodelingprep.com/financial-summary/ZWS'>Zurn Elkay Water Solutions Corporation (NYSE:ZWS)</a> shares are down around 22% since the company’s Q2 earnings release, with broad market pressure exacerbated by lowered near-term Elkay guidance.</p> 
<p>Analysts at Oppenheimer provided their views on the company, noting that they understand investor concerns/pushback regarding the reset of near-term merger expectations, but view the severity of share weakness as materially overdone given the strong setup for core Zurn and still-compelling strategic and medium-term financial upside of the Zurn-Elkay combination. </p>
<p>The analysts anticipate Zurn Elkay will prove resilient over the coming quarters, and consider the company’s valuation excessively discounted given the quality/growth prospects of the combined entity.</p>
<p>The analysts maintained their 2022 EBITDA estimate of $280 million and slightly lowered their 2023 EBITDA estimate to $385 million from $387 million.</p>

NYSE:ZWS